# Vinita Gupta

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/vinita-gupta
Canonical HTML page: https://getbiobrief.com/entity/vinita-gupta

## Timeline

- **2026-07-21**: Spin-Out Announcement — Lupin announced the spin-out of LNP7457 and LNP8701 into Kaveri Therapeutics, along with the leadership appointments and funding structure.
- **2026-06**: LNP8701 ASCO Data — Lupin presented positive clinical data for the SOS1 inhibitor LNP8701 at the 2026 ASCO annual meeting.
- **2025-06**: LNP7457 ASCO Data — Lupin presented positive clinical data for the PRMT5 inhibitor LNP7457 at the 2025 ASCO annual meeting.

## Recent coverage (1 stories)

### PRMT5 & SOS1 Inhibitors Spin Out as Kaveri; 2 Programs with ASCO Data Seek Capital
2026-07-27 11:16:02 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

Lupin’s oncology pipeline yields a new standalone startup, Kaveri Therapeutics, built around PRMT5 inhibitor LNP7457 and SOS1 inhibitor LNP8701. Both compounds showed encouraging clinical data at ASCO 2025 and 2026, and the biotech will now seek external funding to advance global trials.
Full story: https://getbiobrief.com/story/prmt5-sos1-inhibitors-kaveri-bio

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.